• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉瘤:在三个欧洲地区的基于人群的研究中,初始诊断与集中专家审查之间的一致性。

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.

机构信息

University Lyon, EAM 4129 Health Individual Society, Hôtel Dieu, Lyon; Centre Léon Bérard, Lyon, France.

Veneto Institute of Oncology (IOV), IRCCS, Padova, Italy.

出版信息

Ann Oncol. 2012 Sep;23(9):2442-2449. doi: 10.1093/annonc/mdr610. Epub 2012 Feb 13.

DOI:10.1093/annonc/mdr610
PMID:22331640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3425368/
Abstract

BACKGROUND

Sarcomas represent a heterogeneous group of tumors. Accurate determination of histological diagnosis and prognostic factors is critical for the delineation of treatment strategies. The contribution of second opinion (SO) to improve diagnostic accuracy has been suggested for sarcoma but has never been established in population-based studies.

METHODS

Histological data of patients diagnosed with sarcoma in Rhone-Alpes (France), Veneto (Italy) and Aquitaine (France) over a 2-year period were collected. Initial diagnoses were systematically compared with SO from regional and national experts.

RESULTS

Of 2016 selected patients, 1463 (73%) matched the inclusion criteria and were analyzed. Full concordance between primary diagnosis and SO (the first pathologist and the expert reached identical conclusions) was observed in 824 (56%) cases, partial concordance (identical diagnosis of connective tumor but different grade or histological subtype) in 518 (35%) cases and complete discordance (benign versus malignant, different histological type or invalidation of the diagnosis of sarcoma) in 121 (8%) cases. The major discrepancies were related to histological grade (n = 274, 43%), histological type (n = 144, 24%), subtype (n = 18, 3%) and grade plus subtype or grade plus histological type (n = 178, 29%).

CONCLUSION

More than 40% of first histological diagnoses were modified at second reading, possibly resulting in different treatment decisions.

摘要

背景

肉瘤是一组异质性肿瘤。准确确定组织学诊断和预后因素对于制定治疗策略至关重要。已经有人建议第二意见(SO)有助于提高肉瘤的诊断准确性,但尚未在基于人群的研究中得到证实。

方法

在 2 年的时间里,收集了罗纳-阿尔卑斯大区(法国)、威尼托大区(意大利)和阿基坦大区(法国)诊断为肉瘤的患者的组织学数据。对初始诊断进行了系统比较,以确定与区域和国家专家的 SO 是否一致。

结果

在 2016 名入选患者中,有 1463 名(73%)符合纳入标准并进行了分析。在 824 例(56%)病例中,主要诊断与 SO(第一病理学家和专家得出了相同的结论)完全一致,518 例(35%)部分一致(结缔组织肿瘤的相同诊断,但不同的分级或组织学亚型),121 例(8%)完全不一致(良性与恶性、不同的组织学类型或取消肉瘤的诊断)。主要差异与组织学分级(n = 274,43%)、组织学类型(n = 144,24%)、亚型(n = 18,3%)以及分级加亚型或分级加组织学类型(n = 178,29%)有关。

结论

超过 40%的首次组织学诊断在第二次阅读时被修改,这可能导致不同的治疗决策。

相似文献

1
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.肉瘤:在三个欧洲地区的基于人群的研究中,初始诊断与集中专家审查之间的一致性。
Ann Oncol. 2012 Sep;23(9):2442-2449. doi: 10.1093/annonc/mdr610. Epub 2012 Feb 13.
2
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.对罗讷-阿尔卑斯地区综合且前瞻性肉瘤患者系列中初始诊断与中心病理复查之间一致性的流行病学评估。
BMC Cancer. 2010 Apr 19;10:150. doi: 10.1186/1471-2407-10-150.
3
[Histopathological diagnostic concordance in bone and soft tissue sarcomas between two comprehensive cancer centers from eastern and western Europe: a collaborative experience].[欧洲东部和西部两个综合癌症中心之间骨与软组织肉瘤的组织病理学诊断一致性:一项合作经验]
Ann Pathol. 2015 Jan;35(1):32-40. doi: 10.1016/j.annpat.2014.11.002. Epub 2014 Dec 23.
4
The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.软组织和内脏肉瘤、GIST 和硬纤维瘤的集中组织学检查的节省效果:法国肉瘤组病理学家的经验。
PLoS One. 2018 Apr 5;13(4):e0193330. doi: 10.1371/journal.pone.0193330. eCollection 2018.
5
A European project on incidence, treatment, and outcome of sarcoma.一个关于肉瘤发病率、治疗和结果的欧洲项目。
BMC Public Health. 2010 Apr 12;10:188. doi: 10.1186/1471-2458-10-188.
6
Discordance Between the Initial Diagnosis of Sarcomas and Subsequent Histopathological Revision and Molecular Analyses in a Sarcoma Reference Center in Brazil.巴西一家肉瘤参考中心肉瘤的初始诊断与后续组织病理学修正及分子分析之间的不一致性。
JCO Glob Oncol. 2024 Jul;10:e2300431. doi: 10.1200/GO.23.00431.
7
Enhanced accuracy and reduced delay in diagnosing bone tumors within an expert sarcoma network: A nationwide study.提高肉瘤专家网络中骨肿瘤诊断的准确性和减少延迟:一项全国性研究。
Eur J Surg Oncol. 2024 Jun;50(6):108271. doi: 10.1016/j.ejso.2024.108271. Epub 2024 Mar 18.
8
Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG).国家罕见妇科癌症网络(TMRG)中的二次审查揭示的潜在组织学差异。
Gynecol Oncol. 2022 Jun;165(3):637-641. doi: 10.1016/j.ygyno.2022.03.019. Epub 2022 Apr 4.
9
Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions.临床医生在肉瘤患者管理中对实践指南的依从性与不依从性:两个欧洲地区的成本效益评估。
BMC Health Serv Res. 2012 Mar 28;12:82. doi: 10.1186/1472-6963-12-82.
10
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.利用专家病理审查网络,四年间全国范围内的中间恶性肉瘤和结缔组织肿瘤的发病率。
PLoS One. 2021 Feb 25;16(2):e0246958. doi: 10.1371/journal.pone.0246958. eCollection 2021.

引用本文的文献

1
ASO Practice Guidelines Series: Soft Tissue Sarcoma of the Extremities and Superficial Trunk.美国骨科学会(ASO)实践指南系列:四肢及浅表躯干软组织肉瘤
Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18223-7.
2
Adoptive T-Cell Therapy in Sarcomas.肉瘤的过继性T细胞疗法
Curr Oncol Rep. 2025 Aug 14. doi: 10.1007/s11912-025-01706-x.
3
Clinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registry.11132例脂肪肉瘤患者的临床表现、治疗及预后:一项基于NETSARC+注册研究的人群研究
Lancet Reg Health Eur. 2025 Jul 31;57:101403. doi: 10.1016/j.lanepe.2025.101403. eCollection 2025 Oct.
4
RareNet: a deep learning model for rare cancer diagnosis.RareNet:一种用于罕见癌症诊断的深度学习模型。
Sci Rep. 2025 Jul 2;15(1):22732. doi: 10.1038/s41598-025-08829-y.
5
Superiority of targeted RNA sequencing for fusion detection and subtype diagnosis in Chinese sarcoma patients: a multicenter study.靶向RNA测序在中国肉瘤患者融合检测和亚型诊断中的优越性:一项多中心研究
Exp Hematol Oncol. 2025 May 14;14(1):70. doi: 10.1186/s40164-025-00663-2.
6
Landscape of ultra-rare sarcomas: a nationwide study for epidemiology and prognosis.超罕见肉瘤的全貌:一项关于流行病学和预后的全国性研究
ESMO Open. 2025 May;10(5):105097. doi: 10.1016/j.esmoop.2025.105097. Epub 2025 May 12.
7
ASO Practice Guidelines Series: Multidisciplinary Management of Retroperitoneal Sarcomas.血管球囊成形术实践指南系列:腹膜后肉瘤的多学科管理
Ann Surg Oncol. 2025 May 9. doi: 10.1245/s10434-025-17284-y.
8
Enhancing precision in sarcoma diagnosis: nCounter fusion panel implementation in a middle-income country.提高肉瘤诊断的精准度:在中等收入国家实施nCounter融合检测平台
Ther Adv Med Oncol. 2025 Mar 14;17:17588359251318159. doi: 10.1177/17588359251318159. eCollection 2025.
9
Pain Accelerates, Swelling and Sensory Disturbances Delay Diagnosis in Mesenchymal Tumors.疼痛会加速间叶组织肿瘤的诊断,而肿胀和感觉障碍则会延迟诊断。
Cancers (Basel). 2025 Feb 3;17(3):510. doi: 10.3390/cancers17030510.
10
Revolutionising osseous biopsy: the impact of artificial intelligence in the era of personalized medicine.革新骨活检:人工智能在个性化医疗时代的影响。
Br J Radiol. 2025 Jun 1;98(1170):795-809. doi: 10.1093/bjr/tqaf018.

本文引用的文献

1
[Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region].[肉瘤的发病率、流行病学及分子生物学。罗纳-阿尔卑斯地区EMS研究的初步结果]
Bull Cancer. 2010 Jun;97(6):629-41. doi: 10.1684/bdc.2010.1117.
2
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.对罗讷-阿尔卑斯地区综合且前瞻性肉瘤患者系列中初始诊断与中心病理复查之间一致性的流行病学评估。
BMC Cancer. 2010 Apr 19;10:150. doi: 10.1186/1471-2407-10-150.
3
A European project on incidence, treatment, and outcome of sarcoma.一个关于肉瘤发病率、治疗和结果的欧洲项目。
BMC Public Health. 2010 Apr 12;10:188. doi: 10.1186/1471-2458-10-188.
4
[Impact of pathological review by an expert on the diagnosis and management of patients with cancer in Aquitania].[专家病理复查对阿基坦尼亚癌症患者诊断与治疗的影响]
Ann Pathol. 2008 Dec;28(6):478-85. doi: 10.1016/j.annpat.2008.09.044. Epub 2008 Nov 17.
5
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network.美国国立综合癌症网络中非霍奇金淋巴瘤患者转诊病理与最终病理的比较
J Clin Oncol. 2008 Nov 1;26(31):5107-12. doi: 10.1200/JCO.2008.16.4061. Epub 2008 Sep 2.
6
Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.软组织肉瘤:ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii89-93. doi: 10.1093/annonc/mdn101.
7
Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhône-Alpes region in France (ARCERRA).法国罗纳-阿尔卑斯地区儿童癌症登记处(ARCERRA)纳入患者的随访:儿童癌症和白血病治疗相关死亡(TRD)随时间的趋势
Pediatr Blood Cancer. 2008 Jun;50(6):1213-20. doi: 10.1002/pbc.21506.
8
The value of expert second opinion in diagnosis of soft tissue sarcomas.专家二次诊断意见在软组织肉瘤诊断中的价值。
J Surg Oncol. 2008 Jan 1;97(1):40-3. doi: 10.1002/jso.20897.
9
Medical practices and cancer care networks: examples in oncology.医疗实践与癌症护理网络:肿瘤学实例
Bull Cancer. 2006 Feb;93(2):E13-20.
10
The evolving classification of soft tissue tumours: an update based on the new WHO classification.软组织肿瘤的分类进展:基于世界卫生组织新分类的更新
Histopathology. 2006 Jan;48(1):3-12. doi: 10.1111/j.1365-2559.2005.02284.x.